Cargando…
Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
BACKGROUND: The expression of the urokinase plasminogen activator receptor (uPAR), a glycosylphosphatidylinositol-anchored protein family member, and the activity of its ligand, urokinase-type plasminogen activator (uPA), have been associated with the invasive and metastatic potentials of a variety...
Autores principales: | Rossmeisl, John H, Hall-Manning, Kelli, Robertson, John L, King, Jamie N, Davalos, Rafael V, Debinski, Waldemar, Elankumaran, Subbiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396930/ https://www.ncbi.nlm.nih.gov/pubmed/28442916 http://dx.doi.org/10.2147/OTT.S132964 |
Ejemplares similares
-
New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
por: Debinski, Waldemar, et al.
Publicado: (2013) -
Canine Butterfly Glioblastomas: A Neuroradiological Review
por: Rossmeisl, John H., et al.
Publicado: (2016) -
Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
por: Ramos, Sofia C., et al.
Publicado: (2017) -
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998) -
In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)